Q3 2015 Holdings
Filed 2015-10-28 | 7 holdings | $174.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Glaukos Corporation(GKOS) | Common Stock | 377322102 | $76.0M | 3,142,217 | 43.6% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $37.5M | 407,416 | 21.5% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $31.1M | 2,215,384 | 17.9% |
| Five Prime Therapeutics, Inc.(FPRX) | Common Stock | 33830X104 | $16.8M | 1,092,152 | 9.6% |
| Achaogen, Inc. | Common Stock | 004449104 | $7.4M | 1,281,152 | 4.2% |
| Biotie Therapies Corp. | ADS | 09074D103 | $3.5M | 268,672 | 2.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $2.0M | 1,048,601 | 1.2% |